rs797045105
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_032861.4(SERAC1):c.262_265dupCATG(p.Gly89fs) variant causes a frameshift, splice region change. The variant allele was found at a frequency of 0.00000192 in 1,560,956 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_032861.4 frameshift, splice_region
Scores
Clinical Significance
Conservation
Publications
- 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_032861.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERAC1 | NM_032861.4 | MANE Select | c.262_265dupCATG | p.Gly89fs | frameshift splice_region | Exon 4 of 17 | NP_116250.3 | ||
| SERAC1 | NR_073096.2 | n.386_389dupCATG | splice_region non_coding_transcript_exon | Exon 4 of 13 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SERAC1 | ENST00000647468.2 | MANE Select | c.262_265dupCATG | p.Gly89fs | frameshift splice_region | Exon 4 of 17 | ENSP00000496731.1 | ||
| SERAC1 | ENST00000606965.5 | TSL:1 | n.262_265dupCATG | splice_region non_coding_transcript_exon | Exon 4 of 13 | ENSP00000475808.1 | |||
| SERAC1 | ENST00000607742.5 | TSL:1 | n.*96_*99dupCATG | splice_region non_coding_transcript_exon | Exon 3 of 15 | ENSP00000475523.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000142 AC: 2AN: 1408798Hom.: 0 Cov.: 26 AF XY: 0.00000284 AC XY: 2AN XY: 703052 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74346 show subpopulations
ClinVar
Submissions by phenotype
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome Pathogenic:3
The p.Gly89AlafsX32 variant in SERAC1 has not been previously reported in individuals with disease or in large population studies. This variant is predicted to cause a frameshift, which would alter the protein’s amino acid sequence beginning at position 89 and lead to a premature termination codon 32 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the SERAC1 gene is an established disease mechanism in individuals with 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome. In summary, this variant is likely pathogenic for 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome in an autosomal recessive manner, though additional data is required to prove the predicted impact on the gene.
This sequence change creates a premature translational stop signal (p.Gly89Alafs*32) in the SERAC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SERAC1 are known to be pathogenic (PMID: 22683713). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with 3-methylglutaconic aciduria (PMID: 33613893). This variant is also known as c.262_265dup (Splice site). ClinVar contains an entry for this variant (Variation ID: 208610). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at